{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:25:52Z","timestamp":1795047952675,"version":"4.10.2"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Shanghai Hongkou District Health Commission","award":["No. 2303-23"],"award-info":[{"award-number":["No. 2303-23"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82302247"],"award-info":[{"award-number":["No. 82302247"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82272040"],"award-info":[{"award-number":["No. 82272040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Program","award":["No. 22PJD014"],"award-info":[{"award-number":["No. 22PJD014"]}]},{"name":"Major Research Plan of National Natural Science Foundation of China","award":["No. 92359204"],"award-info":[{"award-number":["No. 92359204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03841-w","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T14:02:21Z","timestamp":1767708141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-situ \u00b2\u00b2\u00b3Ra-doped calcium-alginate composite microspheres: a high-LET and immunoactivating platform for \u03b1-particle radioembolization in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Jinming","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"3841_CR1","unstructured":"World Health Organization. Cancer: fact sheet. World Health Organization, 3 Feb. 2025, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer. Accessed 1 Sep. 2025."},{"issue":"9822","key":"3841_CR2","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(11)61347-0.","journal-title":"Lancet"},{"key":"3841_CR3","doi-asserted-by":"crossref","unstructured":"Alazawi W, Cunningham M, Dearden J, Foster GR. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther. 2010; 32 (3):344\u2013355. https:\/\/doi.10.1111\/j.1365-2036.2010.04370.x.","DOI":"10.1111\/j.1365-2036.2010.04370.x"},{"key":"3841_CR4","doi-asserted-by":"crossref","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A. Roberts LR A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019; 16 (10):589\u2013604. https:\/\/doi.10.1038\/s41575-019-0186-y.","DOI":"10.1038\/s41575-019-0186-y"},{"key":"3841_CR5","doi-asserted-by":"crossref","unstructured":"Leowattana W, Leowattana T, Leowattana P. Systemic treatment for unresectable hepatocellular carcinoma. World J Gastroenterol.2023; 29 (10):1551\u20131568. https:\/\/doi.10.3748\/wjg.v29.i10.1551.","DOI":"10.3748\/wjg.v29.i10.1551"},{"key":"3841_CR6","doi-asserted-by":"publisher","first-page":"101946","DOI":"10.1016\/j.ctrv.2019.101946","volume":"82","author":"A Vogel","year":"2020","unstructured":"Vogel A. A Saborowski 2020 Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treat Rev 82 101946 https:\/\/doi.org\/10.1016\/j.ctrv.2019.101946.","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"3841_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1007\/s00270-024-03768-z","volume":"47","author":"G Keane","year":"2024","unstructured":"Keane G, Lam M, Braat A, Bruijnen R, Kaufmann N, de Jong H, et al. Transarterial radioembolization (TARE) global practice patterns: an international survey by the cardiovascular and interventional radiology society of Europe (CIRSE). Cardiovasc Intervent Radiol. 2024;47(9):1224\u201336. https:\/\/doi.org\/10.1007\/s00270-024-03768-z.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3841_CR8","doi-asserted-by":"crossref","unstructured":"Sarwar A, Malik MS, Vo NH, Tsai LL, Tahir MM, Curry MP, Catana AM, Bullock AJ, Parker JA, Eckhoff DE, Nasser IA, Weinstein JL, Ahmed M. Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma. Radiology.2024; 311 (2):e231386. https:\/\/doi.10.1148\/radiol.231386.","DOI":"10.1148\/radiol.231386"},{"issue":"5","key":"3841_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.4254\/wjh.v7.i5.738","volume":"7","author":"C Mosconi","year":"2015","unstructured":"Mosconi C, Cappelli A, Pettinato C, Golfieri R. Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: role and perspectives. World J Hepatol. 2015;7(5):738\u201352. https:\/\/doi.org\/10.4254\/wjh.v7.i5.738.","journal-title":"World J Hepatol"},{"issue":"2","key":"3841_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s00259-009-1305-8","volume":"37","author":"AJ Weeks","year":"2010","unstructured":"Weeks AJ, Paul RL, Marsden PK, Blower PJ, Lloyd DR. Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. Eur J Nucl Med Mol Imaging. 2010;37(2):330\u20138. https:\/\/doi.org\/10.1007\/s00259-009-1305-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3841_CR11","doi-asserted-by":"crossref","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015; 15 (7):409\u2013425. https:\/\/doi.10.1038\/nrc3958.","DOI":"10.1038\/nrc3958"},{"key":"3841_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2024.108971","volume":"140","author":"STM Wenker","year":"2025","unstructured":"Wenker STM, van Lith SAM, Tamborino G, Konijnenberg MW, Bussink J, Heskamp S. The potential of targeted radionuclide therapy to treat hypoxic tumor cells. Nucl Med Biol. 2025;140:108971. https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108971.","journal-title":"Nucl Med Biol"},{"key":"3841_CR13","doi-asserted-by":"crossref","unstructured":"Roobol SJ, van den Bent I, van Cappellen WA, Abraham TE, Paul MW, Kanaar R, Houtsmuller AB, van Gent DC, Essers J. Comparison of High- and Low-LET Radiation-Induced DNA Double-Strand Break Processing in Living Cells. Int J Mol Sci. 2020; 21 (18). https:\/\/doi.10.3390\/ijms21186602.","DOI":"10.3390\/ijms21186602"},{"issue":"9","key":"3841_CR14","doi-asserted-by":"publisher","first-page":"e2307448","DOI":"10.1002\/smll.202307448","volume":"20","author":"M Yang","year":"2024","unstructured":"Yang M, Liu H, Lou J, Zhang J, Zuo C, Zhu M, Zhang X, Yin Y, Zhang Y, Qin S, Zhang H, Fan X, Dang Y, Cheng C, Cheng Z, Yu F. Alpha-Emitter Radium-223 induces STING-Dependent pyroptosis to trigger robust antitumor immunity. Small. 2024;20(9):e2307448. https:\/\/doi.org\/10.1002\/smll.202307448.","journal-title":"Small"},{"issue":"1","key":"3841_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00262-013-1462-2","volume":"63","author":"Y Keisari","year":"2014","unstructured":"Keisari Y, Hochman I, Confino H, Korenstein R, Kelson I. Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments. Cancer Immunol Immunother. 2014;63(1):1\u20139. https:\/\/doi.org\/10.1007\/s00262-013-1462-2.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"3841_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00262-014-1626-8","volume":"64","author":"H Confino","year":"2015","unstructured":"Confino H, Hochman I, Efrati M, Schmidt M, Umansky V, Kelson I, et al. Tumor ablation by intratumoral Ra-224-loaded wires induces anti-tumor immunity against experimental metastatic tumors. Cancer Immunol Immunother. 2015;64(2):191\u20139. https:\/\/doi.org\/10.1007\/s00262-014-1626-8.","journal-title":"Cancer Immunol Immunother"},{"key":"3841_CR17","doi-asserted-by":"publisher","unstructured":"Li X, Wang C, Wu Y, Zhang J, Zhang H, Qin S, Tang L, Yu F. Self-Powered \u03b1 radionuclide nanomedicine: Mitochondria-Targeted multimodal energy recycling for amplified radioimmunotherapy. Adv Mater. 2025;e2504612. https:\/\/doi.org\/10.1002\/adma.202504612.","DOI":"10.1002\/adma.202504612"},{"key":"3841_CR18","doi-asserted-by":"crossref","unstructured":"Bellia SR, Feliciani G, Duca MD, Monti M, Turri V, Sarnelli A, Romeo A, Kelson I, Keisari Y, Popovtzer A, Ibrahim T, Paganelli G. Stanganelli I Clinical evidence of abscopal effect in cutaneous squamous cell carcinoma treated with diffusing alpha emitters radiation therapy: a case report. J Contemp Brachytherapy. 2019; 11 (5):449\u2013457. https:\/\/doi.10.5114\/jcb.2019.88138.","DOI":"10.5114\/jcb.2019.88138"},{"key":"3841_CR19","doi-asserted-by":"crossref","unstructured":"Pinter M, Jain RK, Duda DG. The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review. JAMA Oncol. 2021; 7 (1):113\u2013123. https:\/\/doi.10.1001\/jamaoncol.2020.3381.","DOI":"10.1001\/jamaoncol.2020.3381"},{"key":"3841_CR20","doi-asserted-by":"publisher","unstructured":"Poonia P NS, Chhabra K, Kumar C, Sharma TC, Bhagwat VW. Coordinative role of alkali cations in organic synthesis. 2. The chalcone-flavanone system. J Org Chem. 1977;42(20):3311\u20133. https:\/\/doi.org\/10.1021\/jo00440a030.","DOI":"10.1021\/jo00440a030"},{"key":"3841_CR21","doi-asserted-by":"crossref","unstructured":"Abou DS, Thiele NA, Gutsche NT, Villmer A, Zhang H, Woods JJ, Baidoo KE, Escorcia FE, Wilson JJ. Thorek DLJ Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand. Chem Sci. 2021; 12 (10):3733\u20133742. https:\/\/doi.10.1039\/d0sc06867e.","DOI":"10.1039\/D0SC06867E"},{"key":"3841_CR22","doi-asserted-by":"crossref","unstructured":"Milas L, Mason KA, Ariga H, Hunter N, Neal R, Valdecanas D, Krieg AM. Whisnant JK CpG oligodeoxynucleotide enhances tumor response to radiation. Cancer Res. 2004; 64 (15):5074\u20135077. https:\/\/doi.10.1158\/0008-5472.Can-04-0926.","DOI":"10.1158\/0008-5472.CAN-04-0926"},{"key":"3841_CR23","doi-asserted-by":"crossref","unstructured":"Masyuk TV, Ritman EL. LaRusso NF Hepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation. Am J Pathol. 2003; 162 (4):1175\u20131182. https:\/\/doi.10.1016\/s0002-9440(10)63913-2.","DOI":"10.1016\/S0002-9440(10)63913-2"},{"key":"3841_CR24","doi-asserted-by":"crossref","unstructured":"Jia G, Wang T, Li R, Li X, Sun G, Chen W, Peng Y, Cheng C, Yang J, Zuo C. Radioiodine-131-Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Adv Healthc Mater. 2023; 12 (32):e2301559. https:\/\/doi.10.1002\/adhm.202301559.","DOI":"10.1002\/adhm.202301559"},{"key":"3841_CR25","doi-asserted-by":"crossref","unstructured":"Kabakov AE, Yakimova AO. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing. Cancers (Basel). 2021; 13 (5). https:\/\/doi.10.3390\/cancers13051102.","DOI":"10.3390\/cancers13051102"},{"key":"3841_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1875258","volume":"2017","author":"F Xuan","year":"2017","unstructured":"Xuan F, Rong J, Liang M, Zhang X, Sun J, Zhao L, et al. Biocompatibility and effectiveness evaluation of a new hemostatic embolization agent: thrombin loaded alginate calcium microsphere. BioMed Res Int. 2017;1875258. https:\/\/doi.org\/10.1155\/2017\/1875258.","journal-title":"BioMed Res Int"},{"issue":"17","key":"3841_CR27","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"A Kinner","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008;36(17):5678\u201394. https:\/\/doi.org\/10.1093\/nar\/gkn550.","journal-title":"Nucleic Acids Res"},{"key":"3841_CR28","doi-asserted-by":"crossref","unstructured":"Xu D, Ji Z, Qiang LM, Characteristics. Clinical Implication, and Cancer Immunity Interactions of Pyroptosis-Related Genes in Breast Cancer. Front Med (Lausanne). 2021; 8:702638. https:\/\/doi.10.3389\/fmed.2021.702638.","DOI":"10.3389\/fmed.2021.702638"},{"key":"3841_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1150325","volume":"14","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang Y, Zhang Y, Chen C, Liu H, Yang Y, et al. The role of NLRP3 inflammasome in hepatocellular carcinoma. Front Pharmacol. 2023;14:1150325. https:\/\/doi.org\/10.3389\/fphar.2023.1150325.","journal-title":"Front Pharmacol"},{"key":"3841_CR30","doi-asserted-by":"crossref","unstructured":"Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li F, Yang Z, Lu Y, Liu W. Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biol. 2022; 54:102351. https:\/\/doi.10.1016\/j.redox.2022.102351.","DOI":"10.1016\/j.redox.2022.102351"},{"issue":"6","key":"3841_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.2214\/ajr.22.28800","volume":"220","author":"P Torkian","year":"2023","unstructured":"Torkian P, Haghshomar M, Farsad K, Wallace S, Golzarian J, Young SJ. Cancer immunology: impact of radioembolization of hepatocellular carcinoma on immune response modulation. AJR Am J Roentgenol. 2023;220(6):863\u201372. https:\/\/doi.org\/10.2214\/ajr.22.28800.","journal-title":"AJR Am J Roentgenol"},{"key":"3841_CR32","doi-asserted-by":"crossref","unstructured":"Pinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, M\u00ednguez B, Cacciato V, Avellini C, Diaz A, Boyton RJ, Altmann DM, Goldin RD, Akarca AU, Marafioti T, Mauri FA, Casagrande E, Grillo F, Giannini E, Bhoori S. Mazzaferro V Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. J Immunother Cancer. 2021; 9 (9). https:\/\/doi.10.1136\/jitc-2021-003311.","DOI":"10.1136\/jitc-2021-003311"},{"key":"3841_CR33","doi-asserted-by":"crossref","unstructured":"Yang S, Mu C, Liu T, Pei P, Shen W, Zhang Y, Wang G, Chen L, Yang K. Radionuclide-Labeled Microspheres for Radio-Immunotherapy of Hepatocellular Carcinoma. Adv Healthc Mater. 2023; 12 (26):e2300944. https:\/\/doi.10.1002\/adhm.202300944.","DOI":"10.1002\/adhm.202300944"},{"key":"3841_CR34","doi-asserted-by":"crossref","unstructured":"Xiao L, Li Y, Geng R, Chen L, Yang P, Li M, Luo X, Yang Y, Li L, Cai H. Polymer composite microspheres loading (177)Lu radionuclide for interventional radioembolization therapy and real-time SPECT imaging of hepatic cancer. Biomater Res. 2023; 27 (1):110. https:\/\/doi.10.1186\/s40824-023-00455-x.","DOI":"10.1186\/s40824-023-00455-x"},{"key":"3841_CR35","doi-asserted-by":"crossref","unstructured":"Jiang QR, Pu XQ, Deng CF, Wang W, Liu Z, Xie R, Pan DW, Zhang WJ, Ju XJ, Chu LY. Microfluidic Controllable Preparation of Iodine-131-Labeled Microspheres for Radioembolization Therapy of Liver Tumors. Adv Healthc Mater. 2023; 12 (21):e2300873. https:\/\/doi.10.1002\/adhm.202300873.","DOI":"10.1002\/adhm.202300873"},{"key":"3841_CR36","doi-asserted-by":"crossref","unstructured":"Li X, Qian Y, Lu X, Xu M, He S, Zhang J, Song S. Iodine-131 radioembolization boosts the immune activation enhanced by icaritin\/resiquimod in hepatocellular carcinoma. J Control Release. 2025; 378:849\u2013863. https:\/\/doi.10.1016\/j.jconrel.2024.12.064.","DOI":"10.1016\/j.jconrel.2024.12.064"},{"key":"3841_CR37","doi-asserted-by":"crossref","unstructured":"Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709\u2013760. https:\/\/doi.10.1146\/annurev.immunol.20.100301.064842.","DOI":"10.1146\/annurev.immunol.20.100301.064842"},{"key":"3841_CR38","doi-asserted-by":"crossref","unstructured":"Younes AI, Barsoumian HB, Sezen D, Verma V, Patel R, Wasley M, Hu Y, Dunn JD, He K, Chen D, Menon H, Masrorpour F, Gu M, Yang L, Puebla-Osorio N, Cortez MA. Welsh JW Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity. Transl Oncol. 2021; 14 (2):100983. https:\/\/doi.10.1016\/j.tranon.2020.100983.","DOI":"10.1016\/j.tranon.2020.100983"},{"key":"3841_CR39","doi-asserted-by":"crossref","unstructured":"Kim H, Choi B, Mouli SK, Choi H, Harris KR, Kulik LM, Lewandowski RJ, Kim DH. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo-Immuno-Embolization for the Treatment of Hepatocellular Carcinoma. Adv Healthc Mater. 2023; 12 (26):e2300906. https:\/\/doi.10.1002\/adhm.202300906.","DOI":"10.1002\/adhm.202300906"},{"key":"3841_CR40","doi-asserted-by":"crossref","unstructured":"Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity. 1998; 8 (1):89\u201395. https:\/\/doi.10.1016\/s1074-7613(00)80461-6.","DOI":"10.1016\/S1074-7613(00)80461-6"},{"key":"3841_CR41","doi-asserted-by":"crossref","unstructured":"Weigelin B, den Boer AT, Wagena E, Broen K, Dolstra H, de Boer RJ, Figdor CG, Textor J. Friedl P Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun. 2021; 12 (1):5217. https:\/\/doi.10.1038\/s41467-021-25282-3.","DOI":"10.1038\/s41467-021-25282-3"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03841-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03841-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03841-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:59:00Z","timestamp":1770127140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03841-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3841"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03841-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with the guidelines of the Animal Experiment Ethics Committee of Changhai Hospital, Naval Medical University. The study protocol was reviewed and approved by the Committee (Approval No. CHEC (A.E)2025-001, Programme No. 2025-016).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}